Name | Number of supported studies | Average coverage | |
---|---|---|---|
epithelial cell | 3 studies | 20% ± 2% | |
GABAergic neuron | 3 studies | 22% ± 2% | |
glutamatergic neuron | 3 studies | 28% ± 4% |
Insufficient scRNA-seq data for expression of FBXO45 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
esophagus | 100% | 1132.56 | 1444 / 1445 | 100% | 27.39 | 183 / 183 |
brain | 100% | 1982.75 | 2642 / 2642 | 100% | 20.46 | 704 / 705 |
breast | 100% | 682.49 | 459 / 459 | 100% | 22.26 | 1115 / 1118 |
intestine | 100% | 907.42 | 966 / 966 | 99% | 16.94 | 522 / 527 |
bladder | 100% | 864.00 | 21 / 21 | 99% | 19.12 | 499 / 504 |
prostate | 100% | 737.70 | 244 / 245 | 99% | 13.26 | 496 / 502 |
uterus | 99% | 740.17 | 168 / 170 | 100% | 28.30 | 457 / 459 |
stomach | 99% | 725.53 | 356 / 359 | 99% | 16.28 | 283 / 286 |
ovary | 99% | 603.68 | 179 / 180 | 95% | 11.44 | 410 / 430 |
pancreas | 95% | 463.44 | 312 / 328 | 99% | 11.72 | 176 / 178 |
lung | 93% | 605.58 | 536 / 578 | 99% | 24.36 | 1146 / 1155 |
skin | 100% | 1764.89 | 1808 / 1809 | 92% | 13.49 | 434 / 472 |
thymus | 98% | 551.75 | 639 / 653 | 94% | 8.05 | 567 / 605 |
liver | 97% | 455.97 | 219 / 226 | 85% | 7.02 | 344 / 406 |
adrenal gland | 98% | 557.45 | 254 / 258 | 82% | 6.37 | 188 / 230 |
kidney | 92% | 429.55 | 82 / 89 | 78% | 6.23 | 700 / 901 |
lymph node | 0% | 0 | 0 / 0 | 100% | 11.96 | 29 / 29 |
muscle | 100% | 1432.48 | 803 / 803 | 0% | 0 | 0 / 0 |
spleen | 100% | 809.43 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 35.03 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 9.64 | 1 / 1 |
adipose | 100% | 783.07 | 1203 / 1204 | 0% | 0 | 0 / 0 |
blood vessel | 95% | 521.48 | 1269 / 1335 | 0% | 0 | 0 / 0 |
heart | 91% | 494.20 | 781 / 861 | 0% | 0 | 0 / 0 |
peripheral blood | 44% | 524.82 | 407 / 929 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 23% | 1.19 | 18 / 80 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0016567 | Biological process | protein ubiquitination |
GO_0060386 | Biological process | synapse assembly involved in innervation |
GO_0006974 | Biological process | DNA damage response |
GO_0006511 | Biological process | ubiquitin-dependent protein catabolic process |
GO_0001764 | Biological process | neuron migration |
GO_0070936 | Biological process | protein K48-linked ubiquitination |
GO_0021960 | Biological process | anterior commissure morphogenesis |
GO_0021800 | Biological process | cerebral cortex tangential migration |
GO_0043161 | Biological process | proteasome-mediated ubiquitin-dependent protein catabolic process |
GO_0021957 | Biological process | corticospinal tract morphogenesis |
GO_2000300 | Biological process | regulation of synaptic vesicle exocytosis |
GO_0021799 | Biological process | cerebral cortex radially oriented cell migration |
GO_0098978 | Cellular component | glutamatergic synapse |
GO_0005576 | Cellular component | extracellular region |
GO_0042734 | Cellular component | presynaptic membrane |
GO_0045202 | Cellular component | synapse |
GO_0014069 | Cellular component | postsynaptic density |
GO_0099524 | Cellular component | postsynaptic cytosol |
GO_0005737 | Cellular component | cytoplasm |
GO_0045211 | Cellular component | postsynaptic membrane |
GO_0042995 | Cellular component | cell projection |
GO_0019005 | Cellular component | SCF ubiquitin ligase complex |
GO_0099523 | Cellular component | presynaptic cytosol |
GO_0005634 | Cellular component | nucleus |
GO_1990756 | Molecular function | ubiquitin-like ligase-substrate adaptor activity |
GO_0005515 | Molecular function | protein binding |
Gene name | FBXO45 |
Protein name | F-box/SPRY domain-containing protein 1 (F-box only protein 45) (hFbxo45) F-box protein 45 |
Synonyms | FBX45 |
Description | FUNCTION: Component of E3 ubiquitin ligase complex consisting of FBXO45, MYCBP2 and SKP1 . Functions in substrate recognition but plays also an important role in assembly of the complex . Required for normal neuromuscular synaptogenesis, axon pathfinding and neuronal migration (By similarity). Regulates neuron migration during brain development through interaction with N-cadherin/CDH2 after secretion via a non-classical mechanism (By similarity). Plays a role in the regulation of neurotransmission at mature neurons (By similarity). May control synaptic activity by controlling UNC13A via ubiquitin dependent pathway (By similarity). Specifically recognizes TP73, promoting its ubiquitination and degradation. Polyubiquitinates NMNAT2, an adenylyltransferase that acts as an axon maintenance factor, and regulates its stability and degradation by the proteasome . Acts also by ubiquitinating FBXW7 during prolonged mitotic arrest and promotes FBXW7 proteasomal degradation . Induces subsequently an increase in mitotic slippage and prevents mitotic cell death . In response to influenza infection, mediates interferon-lambda receptor IFNLR1 polyubiquitination and degradation through the ubiquitin-proteasome system by docking with its intracellular receptor domain . . |
Accessions | ENST00000311630.7 C9JLC0 P0C2W1 ENST00000440469.1 |